Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth (Status and Outlook) 2022-2028
SKU ID : LPI-19833941 | Publishing Date : 04-Jan-2022 | No. of pages : 89
The United States Amyotrophic Lateral Sclerosis (ALS) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Amyotrophic Lateral Sclerosis (ALS) Treatment market, reaching US$ million by the year 2028. As for the Europe Amyotrophic Lateral Sclerosis (ALS) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Amyotrophic Lateral Sclerosis (ALS) Treatment players cover Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, and Apotex, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis (ALS) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Riluzole
Edaravone (Radicava)
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Drugs Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region